Not AWRW. I am in ARWR that's not my point the point is another Hematologic company. Private or Public. Acerta Pharma has ACP-196 which will put PCYC in dust when APC 196 is approved. Try AGIO, ARIA, BLUE, KITE, TGTX, and even ARGS.. Imbruvica is all news. Its good they are partnering but they need to buy outright in order to strengthen their pipeline. GET A CLUE. PCYC can and will tank like GILD cuz of HEP C competition. Catch my drift or are you like Bob Duggan clueless.
Like our President Robert Duggan is in over his head. All he is doing is selling a successful drug with all these agreements. He can't strike out on his own. Hence this drug will run its course an get replaced by alternative drugs in development or approved. This is happening to the big pharma GILD. Expand your business product depth Robert. Get a clue.